SEPTInvestingStart Free
Stocks/LPCN/SEC Filings/SCHEDULE 13G/A Aug 14, 2026

LPCN SCHEDULE 13G/A: SEC filing

Squadron Capital Management

Filed with the SEC on Aug 14, 2026 · accession 0002050709-26-000023

LPCN filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Aug 14, 2026. A report the company filed with the SEC (the US market regulator). The stock moved +2.4% by the first close after the filing.

Summary of the filing

Squadron Capital Management filed an amended Schedule 13G (13G/A) regarding its ownership position in Lipocine Inc. The filing indicates a change in the reporting person's beneficial ownership of LPCN common stock.

For details, click here →

Key details

Reporting person / shareholderSquadron Capital Management
IssuerLipocine Inc.

How LPCN stock reacted

Close before

$2.06

Aug 13, 2026

First close after

+2.43%

$2.11

5 trading days

+1.46%

$2.09

Since filing

-23.79%

$1.57

✦ Ask GOAX AI about this filing — what it means for LPCN, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for LPCN?

Click here

Frequently asked questions

What did LPCN file with the SEC on Aug 14, 2026?

LPCN filed a SCHEDULE 13G/A (SEC filing). Squadron Capital Management filed an amended Schedule 13G (13G/A) regarding its ownership position in Lipocine Inc. The filing indicates a change in the reporting person's beneficial ownership of LPCN common stock.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did LPCN stock react to this filing?

LPCN closed at $2.06 before the filing and $2.11 on Aug 14, 2026 (+2.43%). Five trading days later: $2.09 (+1.46%).

Other LPCN SEC filings

  • 8-K · SEC filingNov 5, 2026
  • 10-Q · SEC filingNov 5, 2026
  • 8-K · Fda approvalOct 7, 2026
  • 8-K · Fda approvalSep 14, 2026

Get alerts when LPCN files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
LPCN overviewLPCN analysisLPCN newsLatest SEC filings
Source: SEC EDGAR filing 0002050709-26-000023. The summary and key details are extracted by SEPT from the filing and may contain errors. Price reaction uses daily closing prices. Not financial advice.